key: cord-1039576-3c342h1b
authors: Zuckier, Lionel S.
title: Safe pulmonary scintigraphy in the era of COVID-19.
date: 2021-06-22
journal: Semin Nucl Med
DOI: 10.1053/j.semnuclmed.2021.06.021
sha: bf43105e5f8988a65c2aa3e51658feaa8f2481ff
doc_id: 1039576
cord_uid: 3c342h1b

One of the major effects of the COVID-19 pandemic within nuclear medicine was to halt performance of lung ventilation studies, due to concern regarding spread of contaminated secretions into the ambient air. A number of variant protocols for performing lung scintigraphy emerged in the medical literature which minimized or eliminated ventilation scintigraphy, due to the persistent need to provide this critical diagnostic service without compromising the safety of staff and patients. We have summarized and reviewed these protocols, many of which are based on concepts developed earlier in the history of lung scintigraphy. It is possible that some of these interim remedies may gain traction and earn a more permanent place in the ongoing practice of nuclear medicine.

In appreciation of the selfless contribution of our staff to patient care during the COVID-19 pandemic.

In recognition of my colleagues at Montefiore Medical Center, under the leadership of Dr. Leonard M. Freeman, who have created a center of excellence for the scintigraphic evaluation of pulmonary embolism.

In gratitude to Dr. Gregoire LeGal for constructive review of this paper.

ABSTRACT:

One of the major effects of the COVID-19 pandemic within nuclear medicine was to halt performance of lung ventilation studies, due to concern regarding spread of contaminated secretions into the ambient air. A number of variant protocols for performing lung scintigraphy emerged in the medical literature which minimized or eliminated ventilation scintigraphy, due to the persistent need to provide this critical diagnostic service without compromising the safety of staff and patients.

We have summarized and reviewed these protocols, many of which are based on concepts developed earlier in the history of lung scintigraphy. It is possible that some of these interim remedies may gain traction and earn a more permanent place in the ongoing practice of nuclear medicine.

As the COVID-19 pandemic evolved, and populations across the world were successively overrun by the virus, practitioners struggled to maintain healthcare in a manner safe for patients and medical workers alike (1) (2) (3) . In the realm of nuclear medicine, one area that raised concern was performance of ventilation scintigraphy, an integral component of standard nuclear medicine protocols for the determination of pulmonary embolism, due to concern regarding spread of contaminated secretions into the ambient air (4, 5) . Nonetheless, the need for a diagnostic test to exclude pulmonary embolism (PE) remained acute both because symptoms of PE and COVID-19 pneumonia overlap (6) (7) (8) , and because of an association between COVID-19 infection and thromboembolic disease (9) (10) (11) . Widespread relinquishing of scintigraphy in favor of Computed Tomographic Pulmonary Angiography (CTPA) or other radiographic techniques was constrained, at least in part, by variably increased demand on the Computed Tomography (CT) scanner, heightened decontamination protocols (12) , and inability to use contrast in some COVID-19 patients (13, 14) .

The purpose of this article is to survey the origin and implementation of several archetypal approaches to performance of lung scintigraphy during the COVID-19 pandemic, and to consider their potential impact on the future practice of lung scintigraphy.

In the development of scintigraphy for the evaluation of PE, perfusion scintigraphy was introduced as the initial method of assessing embolism in 1964 (15); while sensitive, it was noted to be of low specificity (16) . Presence of perfusion defects was insufficient to establish PE because defects may be secondary, due to reflex vasoconstriction and provoked by regional hypoxia, rather than primary, as in the case of vascular embolism. This reflex is beneficial in that it prevents shunting blood through poorly oxygenated regions of lung thereby maintaining adequate oxygen concentration in pulmonary veins and the systemic arterial circulation.

The current method of lung scintigraphy for the diagnosis of PE therefore developed into an unusual examination that requires documentation of two disparate physiologic processes, pulmonary perfusion and ventilation, which are then contrasted to arrive at a final diagnosis (17) (18) (19) . Perfusion scintigraphy, absent ventilation, can never achieve high specificity for PE.

Although other schemata have been proposed, standard protocols for interpretation of lung scintigraphy promulgated by the Society of Nuclear Medicine and Molecular Imaging (20) and

the European Association of Nuclear Medicine (21) both rely on a combination of perfusion and ventilation scintigraphy as critical components of the diagnostic process (table 1 and 2) .

As a general rule, studies that cause aerosol or droplet formation were deferred during the COVID-19 pandemic, in order to not disperse potentially infectious patient secretions into the environment (22). These concerns were often magnified due to concurrent issues such as insufficient capacity to test for infection (23) , uncertain understanding of how the disease was spread (24) , and basic lack of personal protective supplies such as masks and gloves (25) .

Indeed, escape of radiopharmaceutical from ventilation scintigraphy delivery systems has been frequently investigated over 3 decades, demonstrating presence of a variable degree of leakage from the aerosol device or patient airways into the examination room (26) (27) (28) (29) (30) . A similar phenomenon has also been noted with the newest ventilation radiopharmaceutical, 99m Tc-labeled carbon particles (Technegas), where activity was noted to persist in the imaging room air for over one hour following administration (31, 32) . Patient coughing (5), poor mouth seal (32) , and incomplete nose closure (32, 33) have all been considered possible avenues of dispersal of patient secretions into the air.

A PLETHORA OF POST-PANDEMIC PROPOSALS

The potential spread of droplets or aerosolized secretions from the patient's airways into the environment challenged nuclear medicine practitioners to expeditiously develop protocols for evaluating presence of PE while mitigating risk associated with ventilation scintigraphy. A number of suggestions regarding how to proceed with lung scintigraphy during the COVID-19 era were therefore presented in the nuclear medicine literature, which attempt to address the tension between potential spread of infection when ventilation scintigraphy is performed and the sub-optimal specificity of scintigraphy for detecting PE when ventilation is omitted (34) . These reveal the determination on the part of nuclear medicine physicians to remain clinically relevant without compromising the safety of staff and patients. Interesting, solutions to this novel problem often leverage concepts and techniques developed earlier in the history of nuclear medicine (table 3) which will be referenced in the sections below.

Strategy A. Scintigraphy should not be performed; patients should be referred outside of nuclear medicine.

Advocates of this position hold the core belief that there is no value to perfusion scintigraphy alone, due to the low predictive value of a positive test (PPV), and they also believe that performance of ventilation scintigraphy during the COVID-19 pandemic entails unjustifiable risk to staff and other patients. This opinion was enunciated during the first pandemic wave in early 2020 (35) (36) (37) and is certainly defensible in a situation of high prevalence of infection, unscreened patients, difficulty in procuring personal protective equipment (PPE), and absent caregiver immunity. In their view, any diagnostic information or other advantage derived from ventilation scintigraphy that could not be obtained from complimentary examinations does not outweigh excess risk to healthcare workers and other patients in performing the study.

Patients who would otherwise be evaluated by ventilation and perfusion (V/Q) scintigraphy would instead be referred for non-nuclear medicine examinations such as CTPA or doppler ultrasonography of the lower extremities which do not generate aerosol or droplets.

These alternatives may not be optimal, or even feasible. Doppler ultrasonography for the detection of deep vein thrombosis has a low sensitivity for the diagnosis of PE (38) . Many patients referred to nuclear medicine are precluded from receiving intravenous contrast due to allergy or renal dysfunction; one of the manifestations of COVID-19 infection is azotemia (13, 14) . Finally, the long-term effect of "closing shop" on subsequent resumption of normal activity remains unknown (34) .

Several groups strongly endorsed performing full ventilation-perfusion studies with use of appropriate PPE during the period of the COVID-19 pandemic, an especially cogent approach in areas of low disease prevalence (39) (40) (41) . While appearing diametrically opposed to the prior position that scintigraphy should not be performed, in actuality the two opinions closely align with respect to the inadequacy of performing perfusion scintigraphy without ventilation.

They differ in whether safe ventilation scintigraphy can be achieved. As more has been learned about the infectivity of COVID-19, availability of polymerase chain reaction (PCR) tests to detect COVD-19 has increased, PPE has become more available, and the medical staff have been vaccinated, consensus has now cautiously moved towards performing full V/Q examinations in many situations (42), such as in patients with negative PCR tests or those with recent evidence of immunity. Differences in circumstances, and in the local tolerance for risk, will affect a physician's willingness to proceed with ventilation at any given juncture.

Strategy C. Improve specificity of perfusion scintigraphy by performing radiographic imaging

In the past, several groups have used radiographic information as a replacement or surrogate for ventilation. Sostman evaluated a combination of perfusion scintigraphy and chest radiography, employing modified PIOPED II criteria. Sensitivity and specificity were 85% and 93% respectively, though 21% of the studies were nondiagnostic (43 SPECT-CT, recommending this test as the first-line diagnostic approach followed by ventilation SPECT-CT on the following day when perfusion defects are present (46) . The concept of staged studies will be further elucidated in strategy E, below.

During the COVID-19 pandemic, several groups have reported using perfusion SPECT-CT, without ventilation, as a definitive examination for detection of PE (47) (48) (49) (50) . Of 6 patients with proven diagnosis of PE studied by Das and colleagues, perfusion SPECT-CT was positive in only 4, a surprisingly low fraction (49) . In the era of COVID-19, an additional benefit afforded by the CT component is the ability to screen the lungs for stigmata of infection (50) . An illustrative patient in whom perfusion SPECT-CT was performed is displayed in figure 1 .

Chief criticism of relying on perfusion SPECT-CT in this manner is that while sensitive, it remains insufficiently specific to warrant long term anticoagulation, an intervention which entails a degree of risk (51) (52) (53) . By performing these studies in cancer center populations with elevated pretest prevalence of PE, several groups (44, 49, 50) were able to ensure a sufficiently high positive predictive value in their cohort, in effect co-opting two methods of increasing predictive value. This concept is discussed further in strategy D, below. The fundamental elements that determine predictive values are sensitivity and specificity of the test, as well the pretest (or a priori) probability of disease in a particular patient; this relationship is governed by Bayes' Theorem (55) . As a pragmatic matter, a high pretest probability will give the predictive value of a positive test an additional boost.

In the pre-COVID-19 era, several authors have published results where they achieve adequate positive and negative predictive value of disease based on combining perfusion scintigraphy results with pretest probability (56) (57) (58) (59) . An early iteration of this approach was described in the PISA-PED study which combined clinical assessment with planar perfusion scintigraphy (56) . Probability of PE was determined in 890 consecutive patients based on pretest probability (judged as very likely, possible or unlikely) and results of planar perfusion scintigraphy (described as normal, near-normal, abnormal compatible with PE or abnormal not compatible with PE). Pulmonary angiography and clinical/scintigraphic follow-up were performed in all patients with abnormal scans, yielding a sensitivity of 92% and specificity of 87%. Updating this concept, Bajc retrospectively studied the diagnostic performance of perfusion SPECT scored using a trinary categorization of PE, no PE, or disorder other than PE, in combination with clinical findings in 152 patients (58) . The combination of clinical pre-test probability and SPECT perfusion was compared to ground truth as determined by the referring physician, achieving a sensitivity of 90% and specificity of 95%.

In the period of COVID-19, this strategy has been utilized in the performance of perfusion SPECT-CT on oncology patients, a high-risk group, to boost the predictive value of a positive result to an actionable level of certainty, as we earlier noted with respect to studies by Das (49) and Lu (50) .

Strategy E. Staged examinations with perfusion scintigraphy firstthe inverted Q/V lung scan.

We have noted that the historic function of ventilation scintigraphy is to adjudicate perfusion defects, that is to determine if they are reflexive and secondary to hypoventilation, or primary abnormalities due to a vascular insult. In the typical population of patients seen at lung scintigraphy, only a small fraction of patients will have perfusion defects. The low prevalence of segmental defects in patients with relatively clear chest radiographs begs the question as to why an "inverted" perfusion ventilation protocol has not been more commonly discussed or performed, except in rare exceptions (66) . This may be because of a desire to improve the stochastic properties of the perfusion images by making them sufficiently high-count, or due to the difficulty in ventilating sufficient counts to overwhelm the initial perfusion study (64, 67) . The advent of improved ventilation radiopharmaceutical agents (68) may serve to remedy this latter difficulty.

G. Making sense of the spectrum.

As noted above, a range of algorithms has been presented regarding how to perform ventilation scintigraphy in the time of COVID-19, including some which combine multiple strategies, such as Lu and Macapinlac (50) or Yildirim and Genc (46) . Some algorithms and opinions appear diametrically opposed to others.

A closer look at the context and circumstances associated with these seemingly contradictory proposals reveals a basically consistent underlying understanding. It is important to remember that each opinion put forward reflects a reaction to the pandemic at a specific and unique location and time. Issues such as disease prevalence, availability of PPE, and availability of diagnostic testing vary between locales. A further dimension in the evaluation of PE is the a priori prevalence of disease in the population of patients studied which changes the predictive value of the examination. While it can be tempting to construe differences between authors as bona fide conceptual disagreements, it may be more likely that variation in approaches is due to situational differences and/or differences in the institutional tolerance for risk.

The solutions to reduce ventilation scintigraphy proposed during the recent COVID-19

pandemic had their origins in earlier concepts. It is important for nuclear medicine practitioners to be familiar with prior protocols published in the literature to afford them of options when needed. There are a range of approaches available and they should be carefully titrated against the particular situation at hand. We need to constantly weigh variables such as prevalence of COVID-19, availability of protective measures, and immunity of staff, to tailor and modify protocols as indicated.

Following the profound disruption caused by the COVID-19 pandemic, some of the temporary remedies that we have enacted, including reducing the necessity of ventilation scintigraphy through any of the several techniques that we have reviewed, may gain traction and permanently alter the ongoing practice of nuclear medicine. PE V/Q mismatch of at least one segment or two subsegments that conforms to the pulmonary vascular anatomy (wedge-shaped defects with the base projecting to the lung periphery).

No PE Normal perfusion pattern in keeping with the anatomic boundaries of the lungs.

Matched or reversed-mismatched V/Q defects of any size, shape or number in the absence of mismatch.

Mismatch that does not have a lobar, segmental or subsegmental pattern Nondiagnostic for PE Multiple V/Q abnormalities not typical of specific diseases.

Legend: PEpulmonary embolism; Qperfusion; Vventilation * SPECT imaging preferred to planar scintigraphy. "Tomographic imaging has higher sensitivity and specificity for PE compared with planar imaging." Table 3 . Prior (pre-COVID) models of scintigraphy for the diagnosis of thromboembolic disease that do not utilize ventilation scintigraphy and their application in the COVID-19 era. After Zuckier (34) .

Miniati et al (56) Based on these findings, and the presence of thrombi in the legs on Doppler study, the patient was treated with Apixaban and discharged home.

How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?

COVID-19) Outbreak: What the Department of Radiology Should Know

COVID19 -Nuclear Medicine Departments, be prepared

Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020?

COVID-19 in the Nuclear Medicine Department, be prepared for ventilation scans as well

Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry)

COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19

Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Operational Strategies to Prevent Coronavirus Disease 2019 (COVID-19) Spread in Radiology: Experience From a Singapore Radiology Department After Severe Acute Respiratory Syndrome

Kidney involvement in COVID-19 and rationale for extracorporeal therapies

Renal complications in COVID-19: a systematic review and metaanalysis

Diagnosis of Massive Pulmonary Embolism in Man by Radioisotope Scanning

Perfusion lung scan in normal volunteers

Regional ventilation in the differential diagnosis of pulmonary embolism

The ventilatory lung scan in the diagnosis of pulmonary embolism

Ventilation-perfusion studies in suspected pulmonary embolism

SNM practice guideline for lung scintigraphy 4.0

National Center for Immunization and Respiratory Diseases (NCIRD) DoVD. Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings

Here are the coronavirus testing materials that are in short supply in the US. Quartz

Airborne or droplet precautions for health workers treating COVID-19?

Critical Supply Shortages -The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic

Airborne radioactive contamination following aerosol ventilation studies

Air contamination following aerosol ventilation in the gamma camera room

Technetium-99m DTPA aerosol contamination in lung ventilation studies

The use of a modified technique to reduce radioactive air contamination in aerosol lung ventilation imaging

Potential dose to nuclear medicine technologists from 99mTc-DTPA aerosol lung studies

99m)Tc activity concentrations in room air and resulting internal contamination of medical personnel during ventilation-perfusion lung scans

Safe practice ventilation technique in lung scanning for pulmonary embolism

Complete nose closure and radioaerosol lung ventilation imaging

To everything there is a season: taxonomy of approaches to the performance of lung scintigraphy in the era of COVID-19

The American College of Nuclear Medicine Guidance on Operating Procedures for a Nuclear Medicine Facility During COVID-19 Pandemic

COVID19 impact on nuclear medicine: an Australian perspective

COVID-19: ACR Statement on Nuclear Medicine Ventilation Scans

A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients

Lung scintigraphy for pulmonary embolism diagnosis during the COVID-19 pandemic: does the benefit-risk ratio really justify omitting the ventilation study?

SFMN Explorations Pulmonaires ventilatoires et perfusionnelles

BELNUC. Recommendations for performing V/Q scans in the context of COVID19

Sensitivity and specificity of perfusion scintigraphy combined with chest radiography for acute pulmonary embolism in PIOPED II

Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism

The Utility of Hybrid SPECT/CT Lung Perfusion Scintigraphy in Pulmonary Embolism Diagnosis

The efficiency of hybrid perfusion SPECT/CT imaging in the diagnostic strategy of pulmonary thromboembolism

Is there a role for lung perfusion

CT to rule out pulmonary embolism in COVID-19 patients with contraindications for iodine contrast?

Single photon emission computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines

Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE

Perfusion SPECT/CT to diagnose pulmonary embolism during COVID-19 pandemic

Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography

Diagnosis of pulmonary embolism: conventional ventilation/perfusion SPECT is superior to the combination of perfusion SPECT and nonenhanced CT

Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosis

Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice

Introduction to clinical decision making

Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISA-PED)

A diagnostic strategy for pulmonary embolism based on standardised pretest probability and perfusion lung scanning: a management study

Perfusion SPECT in patients with suspected pulmonary embolism

Perfusion lung scintigraphy for the diagnosis of pulmonary embolism: a reappraisal and review of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis methods

Performance of Low-Dose Perfusion Scintigraphy and CT Pulmonary Angiography for Pulmonary Embolism in Pregnancy

The clinical utility of a diagnostic imaging algorithm incorporating low-dose perfusion scans in the evaluation of pregnant patients with clinically suspected pulmonary embolism

Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 Pandemic

Experience with a Perfusion-Only Screening Protocol for Evaluation of Pulmonary Embolism During the COVID-19 Pandemic Surge (Oral presentation)

Q/V-SPECT CT in times of COVID-19: Changing the order to improve safety without sacrificing accuracy

Berufsverbands Deutscher Nuklearmediziner e.V. Coronavirus SARS-CoV-2: Mögliche Konsequenzen für die nuklearmedizinische Routine

99mTc particle perfusion/99mTc aerosol ventilation imaging using a subtraction technique in suspected pulmonary embolism

Pulmonary thromboembolism: current status report on the role of nuclear medicine

Ventilation-Perfusion SPECT with (99m)Tc-DTPA Versus Technegas: A Head-to-Head Study in Obstructive and Nonobstructive Disease